The Operating Theatre Journal - Flipbook - Page 28
Join us at TORG 2024 Inaugural Scienti昀椀c Conference taking place
from August 7th to 9th in the vibrant city of Ikeja, Lagos, Nigeria.
We are thrilled to extend a warm invitation to you to join us at the TORG 2024 Conference.
This groundbreaking conference promises three days of unparalleled insights, collaboration, and professional development opportunities, all
aimed at enhancing surgical excellence on a global scale. With a diverse array of sessions covering topics such as innovative surgical techniques,
perioperative care challenges, and advancements in pain medicine, the conference offers something for every healthcare professional.
Plus, earn up to 33 Internationally Recognized CPD Credits awarded by the CPD Group, ensuring that your participation contributes to your ongoing
professional development and credentialing. Don’t miss this exceptional opportunity to connect with leading experts, expand your knowledge, and
contribute to the advancement of surgical care worldwide. Register now to secure your spot at this transformative event!
Expected Participants:
Surgeons, Physician Assistants, Anesthesiologists, Theatre and Perioperative Nurses, Recovery staff, Certi昀椀ed Registered Nurse Anesthetists,
Certi昀椀ed Surgical Technologists, First Assistants, Registered Nurse First Assistants, Perfusionists, Residents, Anesthesia Technicians, Anesthesia
Support, Respiratory Technicians, Medical Device Company Representatives, Infection Control Specialists, Quality Assurance Specialists, Health
Information Management Specialists, Patient Advocates, Nutritionists/Dietitians, Occupational Therapists, Physiotherapists, ICU Specialists,
Rehabilitation Specialists, Respiratory Therapists, Pre-op assessment Professionals, Surgical Ward and Outpatients team, Ambulatory Unit
Specialists, Medical Students, Student Nurses and all healthcare professionals.
Your involvement not only bene昀椀ts your organization but also bolsters the advancement of healthcare, patient care, and global access to quality
healthcare. We are excited to have you on board as a sponsor and partner in this extraordinary event.
Registration Process, visit: www.operatingroomissues.org/torg-2024
Early bird (Before May 30 2024)
Late Registration (After May 30, 2024)
Conference Venue: 1 Ostra Close, Opposite NNPC Gas Plant, Off Otunba Jobifele Way, CBD Alausa, Ikeja. Lagos, Nigeria.
Our 2024 conference encompasses a diverse range of topics, all presented by experts from across the globe. This unique event is set to be a
melting pot of ideas, expertise, and innovation. Whether you are a seasoned healthcare professional, a passionate researcher, or an eager student,
this conference offers a wealth of opportunities for personal and professional growth.
At TORG, we champion the power of collaboration and the sharing of knowledge. Together, we aspire to push the boundaries of surgical progress,
elevate patient care, and extend the reach of quality healthcare across the globe.
We eagerly anticipate your presence at the 2024 Inaugural Scienti昀椀c Conference by TORG.
Prepare to become part of something extraordinary - an ultimate scienti昀椀c extravaganza!
For Registration and Sponsorship Enquiries, Email: info@operatingroomissues.org Conference2024@operatingroomissues.org
+353-852079401
+234-8139255242
New Indication Approved for Verdye (Indocyanine Green for
Injection, ICG) for Breast Sentinel Lymph Node Mapping
Diagnostic Green Plc (Diagnostic Green) is pleased to announce the approval of Verdye (ICG) for intraoperative identi昀椀cation of sentinel lymph
nodes and visualisation pathways in breast cancer in Spain.
The presence of lymphatic metastases is an important prognostic factor for the survival of breast cancer. Sentinel lymph node biopsy (SLNB)
continues to be a fundamental component of early breast cancer detection and is the current standard of care to help determine whether cancer
has spread to the lymph nodes.
With the approval of ICG for breast SLNB, surgeons now have an alternative to using Technetium (99mTc) radio-labelled colloids with blue dyes
(BD) to visualise lymph nodes. Using 99mTc is a signi昀椀cant burden for both patients as well as hospitals which includes logistical challenges
associated with pre-procedure administration, the risk of exposure to ionizing radiation for professionals and all the requirements associated with
radiopharmaceutical handling. Additionally, blue dyes can pose signi昀椀cant potential risks including soft tissue necrosis, metabolic and hematologic
side effects, making it infrequently utilised for routine surgical care.
In discussing the approval, Declan Cassells, Managing Director of Diagnostic Green stated that, “This is a great advancement for breast SLN
detection, leveraging the real-time imaging capabilities ICG. The intraoperative use of ICG not only matches or surpasses the accuracy of current
approaches but also notably improves the patient experience, offering a safer and less invasive alternative to traditional methods involving
Technetium and blue dyes for SLN detection.”
The approval was supported by multiple meta-analyses studies which concluded that
• ICG-昀氀uorescence (ICG-F) is superior to BD staining in every metric of breast SLN detection
• ICG-F is non-inferior to both radioisotope (RI)-lymphoscintigraphy and the combination of RI + BD in per-case SLN detection and both per-case
and per-node sensitivity/false negative rate (FNR)
• ICG-F is superior to both RI and RI+BD in per-node SLN detection
Verdye (Indocyanine Green, ICG) is available throughout EMEA and sold through a network of distributors or directly by Diagnostic Green.
For information on how to order Verdye (Indocyanine Green) in speci昀椀c territories, please check out:
https://diagnosticgreen.com/row/distributor-details/ or contact Diagnostic Green at: info@diagnosticgreen.com
28
THE OPERATING THEATRE JOURNAL
www.otjonline.com